1. In vivo effect of sodium valproate on mouse liver
- Author
-
A. Pangali, M. Kairis, A Constantopoulos, Vassiliki Syriopoulou, E. Sarafidou, and Eleftheria Roma
- Subjects
Male ,Time Factors ,Glucuronosyltransferase ,medicine.medical_treatment ,Sodium ,chemistry.chemical_element ,Pharmacology ,Mice ,Cellular and Molecular Neuroscience ,chemistry.chemical_compound ,In vivo ,medicine ,Animals ,Molecular Biology ,Saline ,Valproic Acid ,Dose-Response Relationship, Drug ,biology ,business.industry ,Chemistry ,Gastroenterology ,Alanine Transaminase ,Cell Biology ,Enzyme assay ,Uridine diphosphate ,Liver ,Alanine transaminase ,Pediatrics, Perinatology and Child Health ,biology.protein ,Molecular Medicine ,Anticonvulsants ,Female ,business ,Injections, Intraperitoneal ,medicine.drug - Abstract
The in vivo effect of sodium valproate (SV) on the activity of uridine diphosphate glucuronosyltransferase (UDP-GT) and hepatotoxicity in the mouse liver was studied. Mice were injected intraperitoneally (IP) with SV at doses varying from 50 to 800 mg/kg per day, for six consecutive days (dose-response group) or at a standard dose of 300 mg/g per day for 2-10 days (time-response group), whereas the controls were injected with normal saline. Valproic acid levels had a positive correlation to the dose (P < 0.001) and duration of drug administration (P = 0.006). A gradual increase in UDP-GT activity was observed in doses of up to approximately 400 mg/kg per day, whereas in higher doses the enzyme activity gradually decreased. The time course of UDP-GT activity at the standard dose of 300 mg/kg per day increased progressively, with a maximum up to the sixth day and then had a gradual reduction. Hepatic necrosis (which was unrelated to the dose or the duration of drug administration) was found in 13% of the SV-treated animals and in none of the controls. We conclude that at an optimal dose (300-400 mg/kg per day) and at a time course of 6 days, SV causes liver UDP-GT induction, whereas in higher doses and longer duration of administration, UDP-GT activity is gradually reduced. SV also causes hepatotoxicity unrelated to dose and time course.
- Published
- 1999